Medical News

RSS

DecImmune Therapeutics receives funds to improve ischemia reperfusion injury outcomes

DecImmune Therapeutics announced today that it has received a $1 million equity investment from Astellas Venture Management and has additionally been awarded $2.2 million in Phase II SBIR funding from the National Institutes of Health.

28 Sep 2010

BMC physicians receive $3M NIH grant to identify TB biomarkers

Boston Medical Center has been chosen to lead an investigation aimed at developing novel approaches to prevent tuberculosis. Jerrold J. Ellner, MD, chief of the section of infectious diseases at BMC and professor of medicine at the Boston University School of Medicine, a renowned expert in the field, will serve as principal investigator on the five-year, $3 million grant funded by the National Institutes of Health.

28 Sep 2010

Johnson & Johnson acquires Marus Endovascular

Johnson & Johnson today announced that it has completed the acquisition of Micrus Endovascular, a global developer and manufacturer of minimally invasive devices for hemorrhagic and ischemic stroke. Johnson & Johnson announced its agreement to acquire Micrus on July 12, 2010.

28 Sep 2010

AP poll: Americans who think health law should do more outnumber those who think government should stay out of it

As Republicans seek to use the health law as a major talking point to help them win more seats in Congress, a "new AP poll finds that Americans who think the law should have done more outnumber those who think the government should stay out of health care by 2-to-1." The poll found four in 10 adults think the law didn't go far enough to change the system "regardless of whether they support the law, oppose it or remain neutral. On the other side, about one in five say they oppose the law because they think the federal government should not be involved in health care at all."

28 Sep 2010

Guided Therapeutics files PMA for LightTouch Cervical Scanner

Guided Therapeutics, Inc. announced that it filed its completed premarket approval application (PMA) for the LightTouch Cervical Scanner with the U.S. Food and Drug Administration (FDA) for patients at risk for cervical cancer.

28 Sep 2010

Celiac disease on the rise in adults: Study

According to a new study published Monday in the Annals of Medicine, cases of intestinal disorder known as Celiac disease are on the rise with many adults developing the disease.

28 Sep 2010

Scientists find Alzheimer's Disease reduces human brain cancer growth

Scientists at the Roskamp Institute in Sarasota, Florida, have shown that mice that naturally develop Alzheimer's are able to ward off the growth of brain cancer. In a series of experiments published in the Journal of Neuroscience, they showed that mice that spontaneously develop Alzheimer's Disease are able to dramatically reduce the growth of a human brain cancer.

28 Sep 2010

High estrogen levels linked to lack of concentration: Study

According to a latest research by Canadian scientists high estrogen levels are associated with an inability to pay attention and learn. Researchers at the Concordia University in Montreal conducted this study to assess the link between estrogen and memory and learning. The study was published in the journal Brain and Cognition.

28 Sep 2010

Study finds acupuncture is not effective in stroke recovery

Acupuncture does not appear to aid in stroke recovery, according to a new study published in CMAJ. This study, perhaps the most comprehensive to date as it includes trials published in English language and Asian journals, was a systematic review conducted by researchers in South Korea and the United Kingdom.

28 Sep 2010

KeyVive provides Simplatype mHealth SMS technology to improve healthcare

KeyVive, Inc., a healthcare technology company that uses social media and self management tools to help individuals with chronic illnesses, is dialing up a ground-breaking, HIPAA compliant mHealth technology for people not only affected by diabetes, but also with other diseases.

28 Sep 2010

ATSC to provide software development services for NCI

ATS Corporation, a leading information technology company that delivers innovative technology solutions to government and commercial organizations, today announced that it has been awarded a new contract totaling $13.3 million over a five-year term with the National Cancer Institute.

28 Sep 2010

Rockland receives Phase I SBIR grant to develop assay for monitoring Akt pathway activity

Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop a pharmacodynamic assay to monitor the Akt/mTOR signaling pathway.

28 Sep 2010

Amira submits IND application for AM152 antagonist

Amira Pharmaceuticals, Inc. announced today that it has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for AM152, a novel LPA1 antagonist. If accepted, the IND will enable Amira to begin Phase 1 safety studies with the compound in healthy subjects.

28 Sep 2010

BCBC awards $5 million for cell therapy research in type 1 diabetes

Maike Sander, MD, associate professor of pediatrics and cellular & molecular medicine at the University of California, San Diego School of Medicine has been awarded nearly $5 million by the Beta Cell Biology Consortium (BCBC) to lead an interdisciplinary team in cell therapy research for type 1 diabetes.

28 Sep 2010

Sanofi Pasteur signs agreement to acquire VaxDesign

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group announced today that it has signed a binding agreement for the acquisition of VaxDesign, a privately held U.S. biotechnology company, based in Orlando, Florida, that develops, manufactures and markets in vitro models of the human immune system.

28 Sep 2010

Today's OpEds: Reform and cost control; the GOP 'Pledge'; New York State's Medicaid program

The pledge document does not mention the Republicans' plan should repeal fail to block the annual appropriations needed to carry out reform. That just-say-no approach is flat out irresponsible. The health care reforms are so intertwined that it is hard to eliminate one provision without undermining others

28 Sep 2010

KHN column - Empty promises

In his latest Kaiser Health News column, John Goodman writes: "Let us suppose that Congress did something really silly. Say it passed a law promising everyone a free annual trip to visit the moon.

28 Sep 2010

Sunscreens containing nanoparticles alarms consumer group

The consumer group CHOICE is demanding more honesty from sunscreen manufacturers after many leading brands were found to contain nanoparticles. There is controversy as to whether the particles, which are smaller than 100 billionths of a meter, can penetrate the skin and have harmful side-effects, says CHOICE. However many of these sunscreens contain nano-grade titanium dioxide and zinc oxide that enable them to offer the same sun protection but go on clear and with less skin residue.

27 Sep 2010

Experts predict rise in food prices

With food prices expected to rise by 50 per cent within 10 years experts are planning to discuss the issues in Brisbane. There is to be a three-day summit on food security this week. With the global population touching nine billion by 2050, Australia’s role in feeding the world will be explored.

27 Sep 2010

Baby formula with genetically modified material condemned by Mums

After controversies regarding the use of genetically modified material in the infant formula S-26, the manufacturer is defending it as activists are storming supermarkets in Melbourne and Sydney.

27 Sep 2010